This inventor holds 1 USPTO granted patent. Top assignee: ETH Zurich. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Michael Freeman: Innovator in Methylation Enzymes
Introduction
Michael Freeman is an accomplished inventor based in Feeding Hills, MA (US). He has made significant contributions to the field of biochemistry, particularly in the area of methylation enzymes. His innovative work has led to the development of a unique method for producing n-methylated (poly) peptides.
Latest Patents
Freeman holds a patent for a "Method for producing an n-methylated (poly) peptide." This invention focuses on novel methyl transferase enzymes that methylate backbone amides of (poly)peptides. The patent also encompasses nucleic acids encoding these enzymes, as well as vectors and host cells that contain them. Furthermore, it details the use of these enzymes for modifying (poly)peptides and introduces additional novel enzymes derived from the omphalotin gene cluster.
Career Highlights
Freeman's career is marked by his dedication to advancing the understanding of peptide modification. His work has implications for various applications in biotechnology and pharmaceuticals. He is associated with ETH Zurich, a prestigious institution known for its research and innovation.
Collaborations
Freeman has collaborated with notable colleagues, including Markus Aebi and Markus Kunzler. These partnerships have further enriched his research and contributed to the advancement of his projects.
Conclusion
Michael Freeman's innovative work in the field of methylation enzymes showcases his commitment to scientific advancement. His contributions have the potential to impact various industries, making him a notable figure in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
